Cargando…
Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
BACKGROUND: There are important knowledge gaps in type 2 myocardial infarction (T2MI). Our primary objective was to compare the outcomes of patients with T2MI with those of patients with type 1 myocardial infarction (T1MI). Our secondary objective was to determine whether randomized controlled trial...
Autores principales: | Reid, Christopher, Alturki, Ahmed, Yan, Andrew, So, Derek, Ko, Dennis, Tanguay, Jean-Francois, Bessissow, Amal, Mehta, Shamir, Goodman, Shaun, Huynh, Thao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242509/ https://www.ncbi.nlm.nih.gov/pubmed/32462125 http://dx.doi.org/10.1016/j.cjco.2020.02.005 |
Ejemplares similares
-
Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014) -
Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019) -
Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial
por: Gouda, Pishoy, et al.
Publicado: (2023) -
Regulation of Type 2 Immunity in Myocardial Infarction
por: Xu, Jun-Yan, et al.
Publicado: (2019) -
Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)